Covered recipient · General Payments record
ADAM CONSIGLI
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$2,697.47
- Reported across 143 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $654.84 | 35 |
| Education | $50.40 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $428.51 | 25 |
| PFIZER INC. | $85.91 | 4 |
| Celgene Corporation | $38.19 | 2 |
| Celltrion USA Inc. | $27.77 | 1 |
| Gilead Sciences, Inc. | $27.47 | 1 |
| Ipsen Biopharmaceuticals, Inc | $26.37 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.76 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $22.63 | 1 |
| Phathom Pharmaceuticals, Inc. | $22.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.93 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946027 | CMS |
| ABBVIE INC. | $24.16 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946029 | CMS |
| ABBVIE INC. | $14.72 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946031 | CMS |
| ABBVIE INC. | $2.03 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946033 | CMS |
| ABBVIE INC. | $19.27 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946035 | CMS |
| ABBVIE INC. | $21.09 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946037 | CMS |
| ABBVIE INC. | $18.71 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946039 | CMS |
| ABBVIE INC. | $21.31 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946041 | CMS |
| ABBVIE INC. | $17.86 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946043 | CMS |
| ABBVIE INC. | $11.74 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946045 | CMS |
| ABBVIE INC. | $18.72 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946047 | CMS |
| ABBVIE INC. | $18.29 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946049 | CMS |
| ABBVIE INC. | $19.52 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946051 | CMS |
| ABBVIE INC. | $20.33 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946053 | CMS |
| ABBVIE INC. | $18.11 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946055 | CMS |
| ABBVIE INC. | $10.20 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946057 | CMS |
| ABBVIE INC. | $15.04 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946059 | CMS |
| ABBVIE INC. | $16.85 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946061 | CMS |
| ABBVIE INC. | $15.68 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946063 | CMS |
| ABBVIE INC. | $17.96 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946065 | CMS |
| ABBVIE INC. | $23.55 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946067 | CMS |
| ABBVIE INC. | $21.35 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946069 | CMS |
| ABBVIE INC. | $16.94 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946071 | CMS |
| ABBVIE INC. | $11.85 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946073 | CMS |
| ABBVIE INC. | $14.30 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106946075 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $22.63 | 08/01/2024 | Education | Undisputed | 01/23/2026 | 1146983805 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.76 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118198300 | CMS |
| Celgene Corporation | $21.38 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101150565 | CMS |
| Celgene Corporation | $16.81 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101150581 | CMS |
| Celltrion USA Inc. | $27.77 | 04/17/2024 | Education | Undisputed | 01/23/2026 | 1075861695 | CMS |
| Gilead Sciences, Inc. | $27.47 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133710875 | CMS |
| Ipsen Biopharmaceuticals, Inc | $26.37 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091972874 | CMS |
| PFIZER INC. | $16.78 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131292249 | CMS |
| PFIZER INC. | $18.10 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131571337 | CMS |
| PFIZER INC. | $21.46 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132072328 | CMS |
| PFIZER INC. | $29.57 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131225104 | CMS |
| Phathom Pharmaceuticals, Inc. | $22.63 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151157035 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.